FDAnews
www.fdanews.com/articles/72797-cryptome-in-revenue-generating-deal

Cryptome in Revenue-Generating Deal

May 27, 2005

Drug discoverer Cryptome Pharmaceuticals Ltd has signed its first revenue-generating deal with German protein drug discovery firm Xantos Biomedicine AG. Under the deal, Cryptome will use its technology, which identifies hidden or "cryptic" peptide fragments within existing larger proteins, to validate one of Xantos' angiogenic therapeutic leads. Xantos has discovered proteins that mediate the proliferation of cells potentially playing a part in the formation of new blood vessels (angiogenesis) in tumors.

()a href="http://www.smh.com.au/news/Business/Cryptome-in-revenuegenerating-deal/2005/05/26/1116950805995.html" target="_blank">The Sydney Morning Herald